The US Food and Drug Administration (FDA) has expanded the indication for the MitraClip (Abbott) device to include patients with normal mitral valves who develop symptoms of heart failure and moderate ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved clinical outcomes in patients with HF across all quartiles of mitral ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

BOSTON, MA—(UPDATED) Patients with severe symptomatic degenerative mitral regurgitation (MR) ineligible for surgery fare just as well when treated with the Pascal device (Edwards Lifesciences) as ...

At Manatee Memorial Hospital (MMH), proven expertise in minimally invasive mitral valve repair is not just about advanced ...

Among a series of 2,500 patients with mitral regurgitation (MR) treated with the MitraClip (Abbott) in the United States, nearly two-thirds had preexisting CAD, and this was associated with an ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — A novel mitral valve transcatheter edge-to-edge repair system was noninferior to an existing system in ...

Abbott Laboratories (NYSE: ABT) has scored a fresh victory across the Atlantic Ocean. The company announced Monday that it has been granted a CE Mark for its MitraClip G4, the latest version of its ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BOSTON -- ...

Cardiovascular diseases or heart problems are still one of the leading causes of death across the globe, and these include such conditions as coronary artery diseases, hypertension, stroke, and many ...

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.

Versions of the device have been available in the EU since 2008. The G4 had already been approved for use in the U.S. by the Food and Drug Administration. It treats mitral regurgitation, a condition ...